reporting
Reporting of Racial and Ethnic Minority Representation in Early Phase Pediatric Oncology Clinical Trials.
Reporting of Racial and Ethnic Minority Representation in Early Phase Pediatric Oncology Clinical Trials.
Source link
Disparities in Reporting and Representation by Sex, Race, and Ethnicity in Endovascular Aortic Device Trials
J Vasc Surg. 2022 May 24:S0741-5214(22)01590-7. doi: 10.1016/j.jvs.2022.05.003. Online ahead of print.
ABSTRACT
OBJECTIVE: Vulnerable populations i...
Race/ethnicity reporting and representation in US clinical trials: A cohort study
Summary
Background
Systemic progress in improving trial representation is uncertain, and previous analyses of minority trial participation have be...
Reporting on and Reviewing for Race/Racialization, Ethnicity, and Culture
Structural racism has a profound impact on mental health as well as on the care for mental disorders and the outcomes of that care. It has a long h...
Market Pathways - Racial Equity Increasing in Device Trials, But Reporting Remains Low
ARTICLE SUMMARY:
A look at the reported racial composition of device clinical trials is a good news/bad news situation: the inclusion of minority p...
Reporting of Race and Ethnicity in Pediatric Trials Increased from 2011-2020
A new investigation revealed that the number of published pediatric clinical trials that reported participant race and ethnicity increased from 201...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
